CHW Home Visit + Wearable Tech for Dementia Caregivers
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a home visit program for caregivers of people with dementia. It aims to help caregivers manage stress and improve well-being through stress reduction techniques and education on caregiving skills. The study employs wearable technology, such as a smartwatch and ring, to monitor stress and sleep. It suits those who are primary caregivers for someone with dementia and belong to Latino, Vietnamese, Korean, or non-Hispanic White communities. Participants must be willing to wear the monitoring devices and have no major health issues that prevent their use. As an unphased trial, this study provides caregivers the opportunity to enhance their caregiving skills and well-being through innovative support methods.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It mainly focuses on the use of wearable technology and does not mention medication changes.
What prior data suggests that this intervention is safe for dementia caregivers?
Research has shown that the Community Health Worker (CHW) Home Visit Program is generally safe for caregivers. In past studies, caregivers who participated in a 12-week home visit program led by CHWs reported positive experiences. This program focused on reducing stress and improving caregiving skills while respecting cultural needs. Although these studies highlighted the program's benefits, they did not identify any serious safety issues or negative effects. This suggests that participants handle the program well. However, as with any new program, ongoing monitoring is important to ensure safety for all involved.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it combines home visits by trained community health workers (CHWs) with wearable technology to provide personalized support for dementia caregivers. Unlike standard treatments, which often focus solely on providing information or medical interventions, this approach offers culturally and language-specific stress reduction techniques and caregiving skills education tailored to Latino, Vietnamese, Korean, and non-Hispanic White caregivers. The use of wearables like smartwatches and rings to monitor physiological responses adds a tech-forward element, allowing for real-time feedback and support. This blend of human interaction and technology aims to address both the emotional and practical challenges faced by caregivers, potentially leading to better outcomes for both caregivers and patients.
What evidence suggests that this trial's interventions could be effective for dementia caregivers?
Research has shown that home visits by community health workers (CHWs), which participants in this trial may receive, can benefit those caring for someone with dementia. One study found that caregivers who participated in a 12-week program of CHW-led home visits felt more supported and less stressed. The close relationship between CHWs and caregivers appears crucial to the program's success. This method may help caregivers manage stress and improve interactions with the person they care for. Another treatment arm in this trial involves using wearable devices to track stress and sleep, potentially enhancing these benefits by providing instant feedback and support.12367
Who Is on the Research Team?
Jung-Ah Lee, PhD
Principal Investigator
Associate Professor
Are You a Good Fit for This Trial?
This study is for family caregivers of people with dementia who are primary care providers. Participants must be Korean, Vietnamese, Latino/Hispanic, or non-Hispanic Whites and speak English, Spanish, Vietnamese, or Korean. They should agree to wear a smartwatch during the day and a smartring at night for 3 months.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Community health workers deliver a 3-month home visit intervention with stress reduction techniques, caregiving education, and wearable technology monitoring.
Follow-up
Participants are monitored for outcomes such as caregiver burden, depression, and self-efficacy at baseline, 3 months, and 6 months.
Extension
Participants in the Usual Care group receive wearable devices after 6 months for continued monitoring.
What Are the Treatments Tested in This Trial?
Interventions
- Attention Control Group with WIoT Technology
- Community Health Worker (CHW) Home Visit Intervention
- Usual Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Irvine
Lead Sponsor
National Institute on Aging (NIA)
Collaborator